07/03/2025 2:30 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2025 2:31 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2025 2:31 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2025 12:01 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2025 12:05 PM | Mancini Marianna (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2025 12:07 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025 4:20 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/12/2025 9:43 AM | FMR LLC (Filed by) Viking Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/24/2025 3:37 PM | Viking Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025 4:25 PM | Viking Therapeutics (Filer)
| Form DEFR14A | |
04/23/2025 4:26 PM | Viking Therapeutics (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for VKTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
04/23/2025 3:01 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2025 9:00 AM | BlackRock, Inc. (Filed by) Viking Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025 6:26 PM | FOEHR MATTHEW W (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2025 6:05 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4/A | |
04/08/2025 4:23 PM | Viking Therapeutics (Filer)
| Form DEFA14A | |
04/08/2025 4:25 PM | Viking Therapeutics (Filer)
| Form ARS | |
04/02/2025 5:29 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 6:05 AM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2025 3:32 PM | Viking Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
01/06/2025 7:15 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 7:16 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 7:11 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 7:12 PM | FOEHR MATTHEW W (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 7:13 PM | Rowland Charles A Jr (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 7:13 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 7:14 PM | MACARTNEY LAWSON (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 7:14 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 4:32 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025 4:25 PM | Mancini Marianna (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025 4:16 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024 5:22 PM | MACARTNEY LAWSON (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2024 5:13 PM | MACARTNEY LAWSON (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024 12:54 PM | VANGUARD GROUP INC (Filed by) Viking Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024 5:31 AM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/28/2024 8:48 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/28/2024 3:37 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024 6:27 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2024 6:28 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2024 3:10 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024 4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad) Right now, we’re witnessing a monumental shift in the world. Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia. |
10/23/2024 3:09 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2024 11:26 AM | STATE STREET CORP (Filed by) Viking Therapeutics (Subject)
| Form SC 13G/A | |
09/20/2024 8:20 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 8:21 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 3:29 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024 6:23 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 6:23 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 7:11 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 7:13 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 7:00 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024 6:47 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024 7:03 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 3:38 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024 3:05 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2024 3:05 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2024 3:05 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 4:55 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024 4:56 PM | Mancini Marianna (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024 4:58 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024 4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024 3:10 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |